<DOC>
	<DOCNO>NCT00996255</DOCNO>
	<brief_summary>The purpose open-label , multi center , phase I study , determine safety profile PHA-793887 administer intravenous infusion patient advanced/metastatic solid tumor . This dose-finding study determine maximum tolerate dose dose PHA-793887 safely use phase II investigation .</brief_summary>
	<brief_title>Dose-Escalation Study PHA-793887 Patients With Advanced/Metastatic Solid Tumors</brief_title>
	<detailed_description />
	<criteria>Advanced/metastatic solid tumor standard therapy exist ECOG ( WHO ) performance status 01 Life expectancy least 3 month Age ≥ 18 year Adequate liver , pancreas renal function Acceptable hematologic status Acute toxic effect prior therapy must resolve NCI CTCAE Grade ≤ 1 Treatment surgery , chemotherapy , investigational therapy must complete least one month prior treatment initiation ( 6 week nitrosoureas Mitomycin C liposomal doxorubicin ) Prior radiation therapy allow 25 % bone marrow reserve Men woman childproducing potential must agree upon use effective contraceptive method In past 6 month : myocardial infarction , unstable angina , coronary/peripheral artery bypass graft , symptomatic congestive heart failure , cerebrovascular accident transient ischemic attack , pulmonary embolism , deep vein thrombosis Known brain metastasis Major surgery , diagnostic surgery , within 4 week prior Day 1 Active , uncontrolled bacterial , viral , fungal infection , require systemic therapy Pregnant breast feed woman Known infection HIV , active hepatitis B hepatitis C Patients exhibit allergic reaction similar structural compound , biological agent , formulation History pancreatitis disorder make patient risk pancreatitis Previous history current presence neurological disorder Patients preexist symptoms peripheral neuropathy relate prior anticancer therapy ( y ) Concomitant treatment may associate peripheral neuropathy Other severe concurrent condition could compromise protocol objective .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>